Sykdomsbegrensende legemidler for behandling av attakkpreget multippel sklerose, inkludert rituximab. En metodevurdering
Cited by Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) on
SBU is an independent national authority, tasked by the government with assessing health care and social service interventions from a broad perspective, covering medical, economic, ethical and social aspects.